Seeyond’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $104K | Sell |
438
-6,189
| -93% | -$1.47M | 0.01% | 556 |
|
|
2022
Q3 | $1.33M | Buy |
6,627
+3,091
| +87% | +$618K | 0.16% | 189 |
|
|
2022
Q2 | $515K | Sell |
3,536
-71
| -2% | -$10.3K | 0.06% | 447 |
|
|
2022
Q1 | $588K | Sell |
3,607
-3,837
| -52% | -$625K | 0.06% | 447 |
|
|
2021
Q4 | $1.26M | Hold |
7,444
| – | – | 0.12% | 295 |
|
|
2021
Q3 | $1.41M | Sell |
7,444
-2,311
| -24% | -$436K | 0.14% | 255 |
|
|
2021
Q2 | $1.65M | Buy |
9,755
+44
| +0.5% | +$7.46K | 0.15% | 218 |
|
|
2021
Q1 | $1.37M | Sell |
9,711
-10,457
| -52% | -$1.48M | 0.14% | 243 |
|
|
2020
Q4 | $2.62M | Buy |
20,168
+2,935
| +17% | +$381K | 0.27% | 84 |
|
|
2020
Q3 | $2.51M | Buy |
17,233
+1,802
| +12% | +$262K | 0.27% | 84 |
|
|
2020
Q2 | $2.29M | Buy |
15,431
+9,048
| +142% | +$1.34M | 0.26% | 93 |
|
|
2020
Q1 | $364K | Buy |
6,383
+5,034
| +373% | +$287K | 0.05% | 423 |
|
|
2019
Q4 | $155K | Hold |
1,349
| – | – | 0.02% | 570 |
|
|
2019
Q3 | $108K | Hold |
1,349
| – | – | 0.01% | 590 |
|
|
2019
Q2 | $98K | Sell |
1,349
-296
| -18% | -$21.5K | 0.01% | 618 |
|
|
2019
Q1 | $154K | Hold |
1,645
| – | – | 0.01% | 570 |
|
|
2018
Q4 | $120K | Buy |
+1,645
| New | +$120K | 0.02% | 573 |
|